Phibro Animal Health
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 7 months.
- Recent price momentum is -11.2% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 2.5% of float.
- Analyst tilt is Hold.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2849 U.S. stocks StockVane covers.
Last computed: 2026-11-21 14:27 UTC
Data coverage: 5 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation A
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 13.3x | Better than 64% |
| Forward P/E | 11.1x | Better than 74% |
| Price / Sales | 0.9x | Better than 79% |
| P/E vs own 5-yr range | 20th pctl | Better than 85% |
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 15.8% | Better than 77% |
| Net income CAGR (3Y) | 45.2% | Better than 87% |
| Free cash flow CAGR (3Y) | 34.7% | Better than 77% |
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 33.8% | Better than 39% |
| Operating margin | 12.8% | Better than 59% |
| Net margin | 6.6% | Better than 48% |
| Return on equity | 29.7% | Better than 87% |
| Return on invested capital | 11.7% | Better than 74% |
Momentum C+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -8.1% | Better than 55% |
| 6-month return | 0.8% | Better than 57% |
| 12-month return (ex latest month) | -3.2% | Better than 30% |
| Distance below 52-week high | 44.2% | Better than 24% |
Financial Health C-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.0x | Better than 72% |
| Debt to assets | 52.5% | Better than 13% |
| Interest coverage | 4.1x | Better than 52% |
| Free cash flow / net income | 9.9% | Better than 3% |
Analyst View N/A
What the Street thinks: share of Buy ratings and upside to the average target.
Not enough data to grade this factor.
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 34.08
- Open
- 34.01
- Day range
- 33.27 - 34.54
- Avg price
- 33.51
- Volume
- 155.54K
- Turnover
- 5.21M
- Turnover ratei
- 0.74%
- Volume ratioi
- 0.94
- Amplitudei
- 3.74%
- 52-week rangei
- 28.04 - 59.64
Valuation
- P/Ei
- 13.70
- P/E (TTM)i
- 13.32
- P/Bi
- 3.24
- EPSi
- 2.43
- Book value / shi
- 10.29
- Net profit
- 98.66M
- Net assets
- 417.67M
Share structure
- Market cap
- 1.35B
- Float capi
- 696.10M
- Shares out
- 40.60M
- Float sharesi
- 20.91M
Dividend & listing
- Div yield (TTM)i
- 1.44%
- Dividend (TTM)
- 0.48
- Listing date
- 1970-01-01
44.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+239.97K net over the window
Short interest
- Shares short
- 1.02M
- % of floati
- 2.51%
- Days to coveri
- 6.42
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Phibro Animal Health (PAHC)?
Phibro Animal Health last traded at 33.29. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Phibro Animal Health's market cap?
About 1.35B.
What is the P/E ratio of Phibro Animal Health?
The trailing twelve-month P/E is 13.32, below its own 5-year average of 39.11 — toward the bottom of its historical range (20.49% percentile). See the Valuation tab for the full history.
Does Phibro Animal Health pay a dividend?
Yes. The trailing dividend yield is 1.44%. Per-share dividends have risen or held for 7 straight years through 2025. See the Dividends tab for the full payment history.
Is Phibro Animal Health a buy according to analysts?
The consensus of 2 analysts is a Hold rating, with an average 12-month price target of 45.00, which implies 35.2% upside from the current price. This is not investment advice.
What is Phibro Animal Health's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Phibro Animal Health a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Phibro Animal Health discussion 0 comments